Hypofractionated Versus Standard Fractionated Whole Breast Irradiation to Node-negative Breast Cancer Patients
NCT00909818 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 976
Last updated 2021-08-24
Summary
The purpose of this study is to investigate the difference in late radiation morbidity between hypofractionated and standard fractionated breast irradiation given to women operated with breast conservation for early breast cancer.
Conditions
- Breast Cancer
- Carcinoma in Situ of the Breast
Interventions
- RADIATION
-
standard fractionated radiotherapy
standard fractionated radiotherapy 50 Gy/25 fractions
- RADIATION
-
hypofractionated radiotherapy
hypofractionated radiotherapy 40 Gy/15 fractions
Sponsors & Collaborators
-
Danish Cancer Society
collaborator OTHER -
Danish Breast Cancer Cooperative Group
lead OTHER
Principal Investigators
-
Lars Stenbygaard, MD · Aalborg University Hospital
-
Birgitte Offersen, MD, Ph.D · Aarhus University Hospital
-
Erik Jakobsen, MD · Vejle Hospital
-
Mette H Nielsen, MD, phd · Odense University Hospital
-
Birgitte Offersen, MD, phd · Aarhus University Hospital
-
Mechthild Krause, M.D., Prof · University Clinic Carl Gustav Carus Dresden
-
Andreas Schreiber, M.D., Ph.D. · Praxis für Strahlentherapie am Klinikum Dresden-Friedrichstadt
-
Ingvil Mjaaland, M.D. · Helse Stavanger HF, Sorlandet Sykehus HF
-
Unn-Miriam Kasti, M.D. · Kristiansand Sykehus
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 41 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-05-14
- Primary Completion
- 2024-05-31
- Completion
- 2024-05-31
Countries
- Denmark
Study Locations
More Related Trials
-
Efficacy and Safety of Ultra_HYPofractionated RadiotHerapy in Women With BrEast CaNcer Receiving Regional Nodal Radiation vs Nodal Moderate Hypofractionated Radiotherapy
NCT05665920 ·Status: RECRUITING ·Phase: NA
-
Prospective Trial of Two Prone Breast Radiotherapy Techniques With Randomization to Concurrent Versus Weekly Boost
NCT01591811 ·Status: COMPLETED ·Phase: PHASE3
-
Prophylactic Irradiation to the Contralateral Breast for BRCA Mutation Carriers Undergoing Treatment for Breast Cancer
NCT00496288 ·Status: UNKNOWN ·Phase: PHASE2
-
Accelerated Radiotherapy Outcomes in Women
NCT00156130 ·Status: COMPLETED
-
Surveillance Imaging Modalities for Breast Cancer Assessment
NCT02212834 ·Status: COMPLETED
-
Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Carcinoma
NCT03422003 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Hypofractionated Radiation Therapy for Patients With Breast Cancer Receiving Regional Nodal Irradiation
NCT02958774 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of an Apoptotic Test for Predicting Late Toxicities After Radiotherapy in Breast and Prostate Cancer Patients
NCT00893035 ·Status: COMPLETED
-
Determination of Predictive Genetic Markers of Toxicity After Hypofractionated Radiotherapy in Breast Cancer Patients Post-Conservative Surgery
NCT01316328 ·Status: COMPLETED
-
Partial Breast Re-irradiation in Women in Women with Locally Recurrent Breast Cancer Previously Treated with Conservative Surgery and Whole Breast Irradiation
NCT05772390 ·Status: RECRUITING ·Phase: PHASE2
-
Real-Time Near-infrared (NIR) Mapping of Sentinel Lymph Nodes in Breast Cancer
NCT01468649 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Dynamic Infrared Thermography in Breast Cancer Diagnostics
NCT02829021 ·Status: COMPLETED ·Phase: NA
-
Impact of 5-fraction Stereotactic Partial Breast Irradiation and Whole Breast Irradiation on Cosmetic Outcome and Patient-reported Outcomes in Early-stage Breast Cancer
NCT03568981 ·Status: UNKNOWN
-
Breast Study to Determine the Ability of Non-Invasive Optical Transillumination Spectroscopy to Predict Breast Density.
NCT00188682 ·Status: COMPLETED
-
Using Clinicopathomic Markers to Predict Neoadjuvant Chemotherapy Response in Breast Cancer
NCT04021069 ·Status: UNKNOWN
-
Multidisciplinary Approach to Breast Cancer Through the Study of Altered Transcriptomic and Immune Accompanied by the Identification of Extractable Markers From the Radiodiagnostic Bioimaging
NCT05809128 ·Status: UNKNOWN
-
National Screening in Denmark With MR Versus Mammography and Ultrasound of Women With BRCA1 or BRCA2 Mutations
NCT00413491 ·Status: UNKNOWN ·Phase: PHASE4
-
Trial Comparing Radioactive Seed Localization to Standard Procedure for Non-palpable Breast Cancers
NCT00225927 ·Status: COMPLETED ·Phase: NA
-
Imaging Versus Cardiac Biomarker Monitored HER2 Directed Therapy in Patients With Breast Cancer
NCT05406635 ·Status: RECRUITING ·Phase: NA
-
Study of Radiation Exposure and Bilateral Breast Cancer
NCT00903591 ·Status: ACTIVE_NOT_RECRUITING
-
Novel Surrogate Markers as Predictors of Radiation Toxicity in Breast Cancer Patients Undergoing Helical Tomotherapy Compared to Standard Radiation Therapy
NCT00563407 ·Status: TERMINATED
-
Shorter Course Radiation for the Treatment of Breast Cancer That Has Spread to Lymph Nodes
NCT02700386 ·Status: COMPLETED ·Phase: PHASE2
-
NIR Hypoxia Imaging of Breast Tumor Response to Neoadjuvant Chemotherapy in Vivo
NCT01934114 ·Status: TERMINATED
-
The Impact of Preoperative Breast MRI in Patients With Breast Cancer Selected for Breast Conserving Surgery
NCT01391806 ·Status: COMPLETED
-
Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer
NCT05528133 ·Status: RECRUITING ·Phase: PHASE2